| 1852年 |
J. J. Bausch opens an optical goods store in Rochester, New York. He borrows $60 from friend Henry Lomb to expand the business, sealing the deal with a handshake. |
| 1853年 |
|
| 1860年 |
J. J. Bausch’s revolutionary Vulcanite eyeglass frames become the first great success for the young company. |
| 1874年 |
Bausch + Lomb begins microscope production. |
| 1886年 |
Edward Bausch, J. J.’s son, patents the “between the lens” iris diaphragm and shutter, helping to give rise to snapshot photography. |
| 1902年 |
Bausch + Lomb introduces the Balopticon slide projector. |
| 1933年 |
Bausch + Lomb introduces Honorary Science Award for high school students; hundreds of thousands of awards have been bestowed since. |
| 1936年 |
The first Ray-Ban aviator goggles for military pilots are produced. |
| 1953年 |
The first films made with the CinemaScope lens premiered in movie theaters, bringing widescreen movie projection to the big screen. |
| 1954年 |
Bausch + Lomb receives an Honorary Award from the Academy of Motion Picture Arts and Sciences for contributions to the advancement of the motion-picture industry. |
| 1964年 |
First images of the surface of the moon are taken using Bausch + Lomb Super Baltar lenses. |
| 1971年 |
Bausch + Lomb launches SofLens® contact lenses, the first mass-produced soft contact lens in the United States. |
| 1981年 |
The company creates its first toric contact lens, and the following year launches its first bifocal contact lens. |
| 1983年 |
Polymer Technology Corporation, a leader in rigid gas permeable contact lenses and solutions, is acquired; the Boston® contact lenses and solutions brands join the Bausch + Lomb portfolio. |
| 1986年 |
Bausch + Lomb expands into ophthalmic pharmaceuticals by acquiring Dr. Mann Pharma, and then the following year, Pharmafair Inc. |
| 1987年 |
ReNu® multipurpose solution for soft contact lenses is launched. |
| 1996年 |
Bausch + Lomb releases 15 new pharmaceutical products, greatly expanding its pharmaceutical portfolio. |
| 1997年 |
Bausch + Lomb establishes a surgical business unit through acquisitions of Chiron Vision and Storz® Ophthalmics, focusing on cataract, refractive and vitreoretinal surgery. |
| 1998年 |
LOTEMAX® (loteprednol etabonate ophthalmic suspension) 0.5% and Alrex® (loteprednol etabonate ophthalmic suspension) 0.2% are launched. |
| 1999年 |
PureVision® contact lenses, the first silicone hydrogel contact lenses in the United States, are launched. |
| 2001年 |
Bausch + Lomb launches PreserVision® brand of eye vitamins, after supporting the landmark National Eye Institute AREDS study. |
| 2005年 |
Retisert® (fluocinolone acetonide intravitreal implant) 0.59 mg is approved by the FDA as an orphan drug. |
| 2006年 |
Bausch + Lomb receives FDA clearance for SofLens® daily disposable contact lenses. |
| 2007年 |
The Stellaris® vision enhancement system is launched, breaking new ground in cataract surgery. |
| 2008年 |
Eyeonics is acquired, adding Crystalens® IOL—the first FDA-approved accommodating intraocular lens for the treatment of cataracts to the Bausch + Lomb portfolio. |
| 2009年 |
Besivance® (besifloxacin ophthalmic suspension) 0.6% is introduced. |
| 2010年 |
Biotrue® multi-purpose solution and PureVision®2 contact lenses are introduced. |
| 2011年 |
Bausch + Lomb launches LOTEMAX® Ointment (loteprednol etabonate ophthalmic ointment) 0.5%. |
| 2012年 |
Bausch + Lomb completes the acquisition of ISTA Pharmaceuticals and adds Bromday® (bromfenac ophthalmic solution) 0.09%, Bepreve® (bepotastine besilate ophthalmic solution) 1.5%, Istalol® (timolol maleate ophthalmic solution) 0.5%, and Vitrase® (hyaluronidase for injection) to its product portfolio. |
| 2012年 |
Bausch + Lomb receives FDA approval for enVista® intraocular lens. |
| 2012年 |
Bausch + Lomb receives FDA clearance for Biotrue® ONEday daily disposable contact lenses. |
| 2012年 |
Bausch + Lomb and Technolas Perfect Vision receive FDA clearance for Victus® Femtosecond Laser Platform. |
| 2013年 |
Bausch + Lomb receives FDA approval for TRULIGN® toric intraocular lens. |
| 2013年 |
PreserVision® AREDS 2 Formula eye vitamin and mineral supplement is introduced. |
| 2014年 |
Bausch + Lomb ULTRA® silicone hydrogel monthly contact lenses and Biotrue® ONEday for Presbyopia contact lenses are introduced. |
| 2015年 |
Synergetics USA Inc. and Acrivet are acquired, expanding the surgical product portfolio to include retina surgery products and veterinary ophthalmic products, respectively. |
| 2016年 |
Acquisition of Alden Optical Laboratories increases access to specialty modalities, including the Zenlens™ scleral lens and NovaKone® soft contact lens for keratoconus. |
| 2016年 |
Bausch + Lomb ULTRA® for Presbyopia is launched. |
| 2017年 |
Bausch + Lomb launches Stellaris Elite® vision enhancement system for cataract and retina surgery. |
| 2017年 |
Bausch + Lomb receives FDA approval for VYZULTA® (latanoprostene bunod ophthalmic solution) 0.024%. |
| 2017年 |
Bausch + Lomb ULTRA® for Astigmatism and Biotrue® ONEday for Astigmatism are introduced. |
| 2018年 |
First-in-class eyeTELLIGENCE™ application is now available exclusively on the Stellaris Elite® vision enhancement system. |
| 2018年 |
Bausch + Lomb launches LUMIFY® redness reliever eye drops, the first and only over-the-counter eye drop with low-dose brimonidine tartrate for the relief of eye redness. |
| 2019年 |
LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% receives FDA approval; enVista® toric MX60ET hydrophobic acrylic intraocular lens (IOL) with StableFlex™ technology is launched. |
| 2019年 |
Bausch + Lomb ULTRA® Multifocal for Astigmatism is launched. |
| 2020年 |
Bausch + Lomb launches INFUSE® daily disposable contact lenses. |
| 2021年 |
Bausch + Lomb receives FDA approval for ClearVisc™ dispersive ophthalmic viscosurgical device (OVD). |
| 2022年 |
Bausch + Lomb launches XIPERE® (triamcinolone acetonide injectable suspension). |
| 2023年 |
Bausch + Lomb receives FDA approved for MIEBO™ (perfluorohexyloctane ophthalmic solution); Bausch + Lomb INFUSE ® |
| 2024年 |
Bausch + Lomb Receives FDA Approval for enVista Envy™ Full Range of Vision Intraocular Lens. |
| 2025年 |
Bausch + Lomb launches Arise™, an orthokeratology lens fitting system that uses intelligent, cloud-based technology to streamline the orthokeratology lens design process. |
